LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Related Questions
What potential financial liabilities or settlement costs could arise for RxSight if the case proceeds, and how would that impact valuation?
Are there any indications of insider activity, share repurchases, or other corporate actions in response to the litigation that could influence the stock?
How might the securities fraud lawsuit affect RXST's short-term price movement and volatility?